Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors

Background: Due to the similarities between clinical signs of toxicity with pyrethroids and cholinesterase inhibitors, if the mistake between these two was made and the patient was treatment with atropine, severe atropine poisoning and even death could occur. This study was conducted to compare the...

Full description

Bibliographic Details
Main Authors: Farzad Gheshlaghi, Zohreh Sedighinia
Format: Article
Language:fas
Published: Isfahan University of Medical Sciences 2011-03-01
Series:مجله دانشکده پزشکی اصفهان
Subjects:
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/704
_version_ 1827838117308006400
author Farzad Gheshlaghi
Zohreh Sedighinia
author_facet Farzad Gheshlaghi
Zohreh Sedighinia
author_sort Farzad Gheshlaghi
collection DOAJ
description Background: Due to the similarities between clinical signs of toxicity with pyrethroids and cholinesterase inhibitors, if the mistake between these two was made and the patient was treatment with atropine, severe atropine poisoning and even death could occur. This study was conducted to compare the clinical signs of two types of poisoning. Methods: In this cross-sectionsl study, 167 patients with pyrethroids poisoning and 167 patients with cholinesterase inhibitors poisoning refered to Noor hospital, Isfahan were assessed. The patients were selected by simple sampelling method and were clinically examined. Finding: The mean age of patients with pyrethroids poisoning was 22.47 and of patients with cholinesterase inhibitors poisoning was 28.80 years. In both groups, men were more than women and poisening by eating was the most prevalent way. The intentional cases were more than accidental ones. The most prevalent signs of cholinesterase inhibitors poisoning were nausea (68.9%), vomiting (43.1%), diarrhea (43.1%), myosis (40.7%), sweating (38.3%) and sialorrhea (36.5%) respectively; also, the most prevalent signs of pyrethroids poisoning were nausea (74.9%), vomiting (61.7%), abdominal cramp (20%), sialorrhea (15.6%), and muscle weakness (12.6%) respectively. Conclusion: Based on this study, the difference between these two types of poisoning symptoms can help the differential diagnosis.
first_indexed 2024-03-12T06:59:26Z
format Article
id doaj.art-d03f59ef72d547b1b5a80b795a4a612b
institution Directory Open Access Journal
issn 1027-7595
1735-854X
language fas
last_indexed 2024-03-12T06:59:26Z
publishDate 2011-03-01
publisher Isfahan University of Medical Sciences
record_format Article
series مجله دانشکده پزشکی اصفهان
spelling doaj.art-d03f59ef72d547b1b5a80b795a4a612b2023-09-02T23:49:35ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2011-03-0128115963968491Clinical Signs of Poisoning with Pyrethroid and Cholinesterase InhibitorsFarzad Gheshlaghi0Zohreh Sedighinia1Associate Professor, Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.Medical Student, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.Background: Due to the similarities between clinical signs of toxicity with pyrethroids and cholinesterase inhibitors, if the mistake between these two was made and the patient was treatment with atropine, severe atropine poisoning and even death could occur. This study was conducted to compare the clinical signs of two types of poisoning. Methods: In this cross-sectionsl study, 167 patients with pyrethroids poisoning and 167 patients with cholinesterase inhibitors poisoning refered to Noor hospital, Isfahan were assessed. The patients were selected by simple sampelling method and were clinically examined. Finding: The mean age of patients with pyrethroids poisoning was 22.47 and of patients with cholinesterase inhibitors poisoning was 28.80 years. In both groups, men were more than women and poisening by eating was the most prevalent way. The intentional cases were more than accidental ones. The most prevalent signs of cholinesterase inhibitors poisoning were nausea (68.9%), vomiting (43.1%), diarrhea (43.1%), myosis (40.7%), sweating (38.3%) and sialorrhea (36.5%) respectively; also, the most prevalent signs of pyrethroids poisoning were nausea (74.9%), vomiting (61.7%), abdominal cramp (20%), sialorrhea (15.6%), and muscle weakness (12.6%) respectively. Conclusion: Based on this study, the difference between these two types of poisoning symptoms can help the differential diagnosis.http://jims.mui.ac.ir/index.php/jims/article/view/704Clinical symptomsToxicityPyrethroidCholinesterase inhibitors
spellingShingle Farzad Gheshlaghi
Zohreh Sedighinia
Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors
مجله دانشکده پزشکی اصفهان
Clinical symptoms
Toxicity
Pyrethroid
Cholinesterase inhibitors
title Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors
title_full Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors
title_fullStr Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors
title_full_unstemmed Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors
title_short Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors
title_sort clinical signs of poisoning with pyrethroid and cholinesterase inhibitors
topic Clinical symptoms
Toxicity
Pyrethroid
Cholinesterase inhibitors
url http://jims.mui.ac.ir/index.php/jims/article/view/704
work_keys_str_mv AT farzadgheshlaghi clinicalsignsofpoisoningwithpyrethroidandcholinesteraseinhibitors
AT zohrehsedighinia clinicalsignsofpoisoningwithpyrethroidandcholinesteraseinhibitors